Besins Healthcare acquires new manufacturing site to boost HRT production capability


Share post:

Besins Healthcare has acquired a pharmaceutical manufacturing site in Drogenbos, Belgium to boost the production of hormonal products including Oestrogel.

Currently, the site which is being used as one of two manufacturing sites for their gel products [the other site being in France], is a strategic purchase to allow Besins Healthcare to increase production of its own products, offering greater efficiencies and greater integration into the company’s supply line.

“In the past year, demand for hormone replacement therapy (HRT) treatment in the United Kingdom and Ireland has dramatically increased, resulting in regrettable disruption to supply of Oestrogel. We are looking at a range of options for increasing supplies of this product in the short, medium and longer term,” said Alexandre Besins, joint CEO for Besins Healthcare.

“Besins strongly believes that by re-integrating our manufacturing capabilities we will have better control over our ability to meet demand and live up to the trust that HCPs and patients have put in us.”

Madelaine McTernan, head of the HRT Supply Taskforce, said: “This is very positive news. Besins continue to play a key role in our ongoing positive engagement with the sector and I welcome this step that should reinforce and expand future production capacity to meet rising demand.”

Besins added: “As a leading hormone company providing HRT treatments, we welcome the growing interest and awareness of the menopause and the impact it can have on patients.”

He added, “At Besins Healthcare we are dedicated to doing everything possible to look after the patients we serve and to be part of a solution, providing treatment and relief to patients in the UK as well as the rest of the world.”


Please enter your comment!
Please enter your name here

Current Issue June 2023

Related articles

A new Haleon report claims growth of pain in the past decade

Consumer health company Haleon, formerly known as GSK, claims that pain's emotional and life impact has grown by...

Viatris to divest some businesses for nearly £3 billion

Drugmaker Viatris said on Sunday (October 1) it had reached agreements to divest some of its businesses for...

Titan PMR set to unveil ‘Titanverse’, a one-stop-shop tech solution for pharmacy businesses

Bristol-based Titan PMR, a technology firm specialising in PMR systems for community pharmacies, is set to roll out...

Six Scotland-based pharmacists recognised at celebratory RPS event in Edinburgh

Six pharmacists based in Scotland were acknowledged by the profession this week during a celebratory event held at...